Question

In: Accounting

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

1

Dec. 31, 20Y3

Dec. 31, 20Y2

2

Assets

3

Cash

$625,820.00

$586,050.00

4

Accounts receivable (net)

227,530.00

209,880.00

5

Inventories

641,480.00

616,920.00

6

Investments

0.00

240,910.00

7

Land

327,510.00

0.00

8

Equipment

704,830.00

554,110.00

9

Accumulated depreciation-equipment

(165,750.00)

(148,570.00)

10

Total assets

$2,361,420.00

$2,059,300.00

11

Liabilities and Stockholders’ Equity

12

Accounts payable (merchandise creditors)

$424,970.00

$405,330.00

13

Accrued expenses payable (operating expenses)

42,810.00

51,640.00

14

Dividends payable

23,200.00

19,840.00

15

Common stock, $2 par

150,000.00

100,000.00

16

Paid-in capital: Excess of issue price over par—common stock

417,500.00

280,000.00

17

Retained earnings

1,302,940.00

1,202,490.00

18

Total liabilities and stockholders’ equity

$2,361,420.00

$2,059,300.00

The income statement for the year ended December 31, 20Y3, is as follows:

1

Sales

$5,368,400.00

2

Cost of goods sold

 3,305,660.00

3

Gross profit

$2,062,740.00

4

Operating expenses:

5

Depreciation expense

$17,180.00

6

Other operating expenses

1,754,452.00

7

Total operating expenses

1,771,632.00

8

Operating income

$291,108.00

9

Other income:

10

Gain on sale of investments

39,110.00

11

Income before income tax

$330,218.00

12

Income tax expense

133,998.00

13

Net income

$196,220.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

a. The investments were sold for $280,020 cash.
b. Equipment and land were acquired for cash.
c. There were no disposals of equipment during the year.
d. The common stock was issued for cash.
e. There was a $95,770 debit to Retained Earnings for cash dividends declared.

Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities. Be sure to complete the heading of the statement. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Enter amounts that represent cash outflows as negative numbers using a minus sign.

Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities. Be sure to complete the heading of the statement. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Enter amounts that represent cash outflows as negative numbers using a minus sign.

Score: 74/131

Livers Inc.

Statement of Cash Flows

1

Cash flows from operating activities:

2

3

4

5

6

7

8

Cash flows from investing activities:

9

10

11

12

13

14

Cash flows from financing activities:

15

16

17

18

19

Cash at the beginning of the year

20

Cash at the end of the year

Solutions

Expert Solution

Hi

Let me know in case you face any issue: Row no. 12 can be left blank or there may be a different style of reporting number.


Related Solutions

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses) 45,000.00 50,000.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $262,580 $246,510 Accounts receivable (net) 95,120 88,540 Inventories 268,530 262,130 Investments 0 101,560 Land 137,730 0 Equipment 296,270 231,760 Accumulated depreciation—equipment (69,360) (62,500) Total assets $990,870 $868,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $179,350 $171,000 Accrued expenses payable (operating expenses) 17,840 22,570 Dividends payable 9,910 7,810 Common stock, $10 par 53,510 42,530 Paid-in...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT